At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
One form of arginine +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Oral Supplementation With One Form of L-arginine on Vascular Endothelial Function in Healthy Subjects Featuring Risk Factors Related to the Metabolic Syndrome.
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement·interventional·Posted Feb 3, 2015·Updated Feb 3, 2015
In Brief
A clinical study evaluating One form of arginine and placebo for Overweight and Hypertriglyceridemic Waist. Completed, enrolled 36 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether oral supplementation with one form of arginine improves vascular endothelial function in healthy subjects with risk factors associated with the metabolic syndrome
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOverweight, Hypertriglyceridemic Waist
CountriesFrance
CollaboratorsInstitut de Recherche Pierre Fabre, Hospital Avicenne, Adeprina
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2014
Primary CompletionMay 2014
Study CompletionSep 2014
First PostedFeb 2015
TodayJul 2026
First PostedFeb 3, 2015
Enrollment StartFeb 1, 2014
Primary CompletionMay 1, 2014
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 11.4 years ago
Interventions
One form of argininedietary
3 capsules containing 0.5g of one form of L-arginine (1.5g) 3 times daily (4.5g per day) for 1 month
placebodietary
3 capsules containing 0.5g cellulose (non active product) 3 times daily (4.5g per day) for 1 month